0001209191-23-010165.txt : 20230216
0001209191-23-010165.hdr.sgml : 20230216
20230216171803
ACCESSION NUMBER: 0001209191-23-010165
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230216
FILED AS OF DATE: 20230216
DATE AS OF CHANGE: 20230216
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Delfini Lisa
CENTRAL INDEX KEY: 0001873253
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38886
FILM NUMBER: 23639389
MAIL ADDRESS:
STREET 1: C/O TREVI THERAPEUTICS, INC.
STREET 2: 195 CHURCH STREET, FL. 14
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Trevi Therapeutics, Inc.
CENTRAL INDEX KEY: 0001563880
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 450834299
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 195 CHURCH STREET
STREET 2: 14TH FLOOR
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
BUSINESS PHONE: 203-304-2499
MAIL ADDRESS:
STREET 1: 195 CHURCH STREET
STREET 2: 14TH FLOOR
CITY: NEW HAVEN
STATE: CT
ZIP: 06510
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2023-02-16
0
0001563880
Trevi Therapeutics, Inc.
TRVI
0001873253
Delfini Lisa
C/O TREVI THERAPEUTICS, INC.
195 CHURCH STREET, 14TH FLOOR
NEW HAVEN
CT
06510
0
1
0
0
Chief Financial Officer
Stock Option (right to buy)
2.67
2023-02-16
4
A
0
187500
0.00
A
2033-02-15
Common Stock
187500
187500
D
This option was granted on February 16, 2023. The 187,500 shares of common stock underlying the option are scheduled to vest as to 25% of the shares on February 16, 2024 and as to the remaining 75% of the shares in equal monthly installments thereafter through February 16, 2027.
/s/ Christopher Galletta, attorney-in-fact
2023-02-16